Entity Details

Primary name KIF5A_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ12840
EntryNameKIF5A_HUMAN
FullNameKinesin heavy chain isoform 5A
TaxID9606
Evidenceevidence at protein level
Length1032
SequenceStatuscomplete
DateCreated1997-11-01
DateModified2021-06-02

Ontological Relatives

GenesKIF5A

GO terms

Show/Hide Table
GOName
GO:0003774 cytoskeletal motor activity
GO:0003777 microtubule motor activity
GO:0005524 ATP binding
GO:0005829 cytosol
GO:0005871 kinesin complex
GO:0005874 microtubule
GO:0006890 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
GO:0007018 microtubule-based movement
GO:0007268 chemical synaptic transmission
GO:0007411 axon guidance
GO:0008017 microtubule binding
GO:0008574 plus-end-directed microtubule motor activity
GO:0016020 membrane
GO:0016192 vesicle-mediated transport
GO:0016887 ATP hydrolysis activity
GO:0019886 antigen processing and presentation of exogenous peptide antigen via MHC class II
GO:0030705 cytoskeleton-dependent intracellular transport
GO:0032839 dendrite cytoplasm
GO:0043204 perikaryon
GO:0045202 synapse
GO:0048471 perinuclear region of cytoplasm
GO:0048489 synaptic vesicle transport
GO:0098971 anterograde dendritic transport of neurotransmitter receptor complex
GO:0099641 anterograde axonal protein transport
GO:1904115 axon cytoplasm
GO:1990049 retrograde neuronal dense core vesicle transport

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Perikaryon

Domains

Show/Hide Table
DomainNameCategoryType
IPR001752 Kinesin motor domainDomainDomain
IPR019821 Kinesin motor domain, conserved siteSiteConserved site
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily
IPR027640 Kinesin-like proteinFamilyFamily
IPR036961 Kinesin motor domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
604187 OMIMSpastic paraplegia 10, autosomal dominant (SPG10)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. The disease is caused by variants affecting the gene represented in this entry.
617235 OMIMMyoclonus, intractable, neonatal (NEIMY)An autosomal dominant neurologic disorder characterized by severe, infantile-onset myoclonic seizures, hypotonia, optic nerve abnormalities, dysphagia, apnea, and early developmental arrest. Brain imaging shows a progressive leukoencephalopathy. Some patients may die in infancy. The disease is caused by variants affecting the gene represented in this entry.
617921 OMIMAmyotrophic lateral sclerosis 25 (ALS25)A form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. ALS25 is an autosomal dominant form with variable adult onset and incomplete penetrance. Disease susceptibility is associated with variants affecting the gene represented in this entry. The mutation NM_004984.2:c.33019A>G encoding the predicted missence variant p.Arg1007Gly, may also affect splicing and induce the skipping of exon 27, resulting in a frameshift and a premature stop codon producing a truncated protein p.Asn999Valfs*39.

Interactions

34 interactions

InteractorPartnerSourcesPublicationsLink
KIF5A_HUMANITSN1_HUMANBioGRID, HPRD, IntAct16169070 details
KIF5A_HUMANASPP2_HUMANBioGRID, HPRD, IntAct16169070 details
KIF5A_HUMANMIPT3_HUMANIntAct17043677 31413325 details
KIF5A_HUMANM4K4_HUMANBioGRID, IntAct20936779 details
KIF5A_HUMANRPGF2_HUMANBioGRID, IntAct20936779 details
KIF5A_HUMANKCNE3_HUMANBioGRID, MINT21900206 details
KIF5A_HUMANPIN1_HUMANBioGRID, MINT21900206 details
KIF5A_HUMANSMN_HUMANBioGRID, MINT21900206 details
KIF5A_HUMANKITH_HUMANBioGRID, MINT21900206 details
KIF5A_HUMANEXOC1_HUMANBioGRID, IntAct17043677 28514442 31413325 details
KIF5A_HUMANTRI55_HUMANBioGRID, IntAct31391242 details
KIF5A_HUMANDTNB_HUMANBioGRID, HPRD14600269 details
KIF5A_HUMANTS101_HUMANBioGRID15256501 details
KIF5A_HUMANYAP1_HUMANBioGRID11278422 details
KIF5A_HUMANNDEL1_HUMANBioGRID30217970 details
KIF5A_HUMANTRI63_HUMANBioGRID31391242 details
KIF5A_HUMANMK10_HUMANBioGRID19525941 details
KIF5A_HUMANCBP_HUMANBioGRID32238831 details
KIF5A_HUMANNCOA2_HUMANHPRD11986669 details
KIF5A_HUMANMDM2_HUMANIntAct20195357 details
KIF5A_HUMANRXRB_HUMANIntAct20195357 details
KIF5A_HUMANPHS_HUMANIntAct20195357 details
KIF5A_HUMANANR27_HUMANIntAct22705394 details
KIF5A_HUMANTRAK1_HUMANMINT24161670 details
KIF5A_HUMANKLC1_HUMANBioGRID, IntAct10491391 22939629 26344197 28514442 9624122 details
KIF5A_HUMANFMR1_HUMANIntAct31413325 details
KIF5A_HUMANTSC1_HUMANMINT21653829 details
KIF5A_HUMANKLC2_HUMANBioGRID10491391 22939629 details
KIF5A_HUMANSTAU1_HUMANBioGRID15303970 details
KIF5A_HUMANINSR_HUMANBioGRID25687571 details
KIF5A_HUMANKLC3_HUMANHPRD10491391 details
KIF5A_HUMANKIF5A_HUMANHPRD10964943 details
KIF5A_HUMANKINH_HUMANHPRD10964943 details
KIF5A_HUMANKIF5C_HUMANHPRD10964943 details